1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Allogeneic Stem Cell Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Adult Stem Cell Therapy 1.2.3 Human Embryonic Stem Cell Therapy 1.2.4 Induced Pluripotent Stem Cell Therapy 1.2.5 Others 1.3 Market by Application 1.3.1 Global Allogeneic Stem Cell Therapy Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Musculoskeletal Disorder 1.3.3 Wounds & Injuries 1.3.4 Cardiovascular Diseases 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Allogeneic Stem Cell Therapy Market Perspective (2016-2027) 2.2 Allogeneic Stem Cell Therapy Growth Trends by Regions 2.2.1 Allogeneic Stem Cell Therapy Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Allogeneic Stem Cell Therapy Historic Market Share by Regions (2016-2021) 2.2.3 Allogeneic Stem Cell Therapy Forecasted Market Size by Regions (2022-2027) 2.3 Allogeneic Stem Cell Therapy Industry Dynamic 2.3.1 Allogeneic Stem Cell Therapy Market Trends 2.3.2 Allogeneic Stem Cell Therapy Market Drivers 2.3.3 Allogeneic Stem Cell Therapy Market Challenges 2.3.4 Allogeneic Stem Cell Therapy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Allogeneic Stem Cell Therapy Players by Revenue 3.1.1 Global Top Allogeneic Stem Cell Therapy Players by Revenue (2016-2021) 3.1.2 Global Allogeneic Stem Cell Therapy Revenue Market Share by Players (2016-2021) 3.2 Global Allogeneic Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Allogeneic Stem Cell Therapy Revenue 3.4 Global Allogeneic Stem Cell Therapy Market Concentration Ratio 3.4.1 Global Allogeneic Stem Cell Therapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Allogeneic Stem Cell Therapy Revenue in 2020 3.5 Allogeneic Stem Cell Therapy Key Players Head office and Area Served 3.6 Key Players Allogeneic Stem Cell Therapy Product Solution and Service 3.7 Date of Enter into Allogeneic Stem Cell Therapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Allogeneic Stem Cell Therapy Breakdown Data by Type 4.1 Global Allogeneic Stem Cell Therapy Historic Market Size by Type (2016-2021) 4.2 Global Allogeneic Stem Cell Therapy Forecasted Market Size by Type (2022-2027) 5 Allogeneic Stem Cell Therapy Breakdown Data by Application 5.1 Global Allogeneic Stem Cell Therapy Historic Market Size by Application (2016-2021) 5.2 Global Allogeneic Stem Cell Therapy Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Allogeneic Stem Cell Therapy Market Size (2016-2027) 6.2 North America Allogeneic Stem Cell Therapy Market Size by Type 6.2.1 North America Allogeneic Stem Cell Therapy Market Size by Type (2016-2021) 6.2.2 North America Allogeneic Stem Cell Therapy Market Size by Type (2022-2027) 6.2.3 North America Allogeneic Stem Cell Therapy Market Size by Type (2016-2027) 6.3 North America Allogeneic Stem Cell Therapy Market Size by Application 6.3.1 North America Allogeneic Stem Cell Therapy Market Size by Application (2016-2021) 6.3.2 North America Allogeneic Stem Cell Therapy Market Size by Application (2022-2027) 6.3.3 North America Allogeneic Stem Cell Therapy Market Size by Application (2016-2027) 6.4 North America Allogeneic Stem Cell Therapy Market Size by Country 6.4.1 North America Allogeneic Stem Cell Therapy Market Size by Country (2016-2021) 6.4.2 North America Allogeneic Stem Cell Therapy Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Allogeneic Stem Cell Therapy Market Size (2016-2027) 7.2 Europe Allogeneic Stem Cell Therapy Market Size by Type 7.2.1 Europe Allogeneic Stem Cell Therapy Market Size by Type (2016-2021) 7.2.2 Europe Allogeneic Stem Cell Therapy Market Size by Type (2022-2027) 7.2.3 Europe Allogeneic Stem Cell Therapy Market Size by Type (2016-2027) 7.3 Europe Allogeneic Stem Cell Therapy Market Size by Application 7.3.1 Europe Allogeneic Stem Cell Therapy Market Size by Application (2016-2021) 7.3.2 Europe Allogeneic Stem Cell Therapy Market Size by Application (2022-2027) 7.3.3 Europe Allogeneic Stem Cell Therapy Market Size by Application (2016-2027) 7.4 Europe Allogeneic Stem Cell Therapy Market Size by Country 7.4.1 Europe Allogeneic Stem Cell Therapy Market Size by Country (2016-2021) 7.4.2 Europe Allogeneic Stem Cell Therapy Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Allogeneic Stem Cell Therapy Market Size (2016-2027) 8.2 Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Type 8.2.1 Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Type (2016-2027) 8.3 Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Application 8.3.1 Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Application (2016-2027) 8.4 Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Region 8.4.1 Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Allogeneic Stem Cell Therapy Market Size (2016-2027) 9.2 Latin America Allogeneic Stem Cell Therapy Market Size by Type 9.2.1 Latin America Allogeneic Stem Cell Therapy Market Size by Type (2016-2021) 9.2.2 Latin America Allogeneic Stem Cell Therapy Market Size by Type (2022-2027) 9.2.3 Latin America Allogeneic Stem Cell Therapy Market Size by Type (2016-2027) 9.3 Latin America Allogeneic Stem Cell Therapy Market Size by Application 9.3.1 Latin America Allogeneic Stem Cell Therapy Market Size by Application (2016-2021) 9.3.2 Latin America Allogeneic Stem Cell Therapy Market Size by Application (2022-2027) 9.3.3 Latin America Allogeneic Stem Cell Therapy Market Size by Application (2016-2027) 9.4 Latin America Allogeneic Stem Cell Therapy Market Size by Country 9.4.1 Latin America Allogeneic Stem Cell Therapy Market Size by Country (2016-2021) 9.4.2 Latin America Allogeneic Stem Cell Therapy Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Allogeneic Stem Cell Therapy Market Size (2016-2027) 10.2 Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Type 10.2.1 Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Type (2016-2027) 10.3 Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Application 10.3.1 Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Application (2016-2027) 10.4 Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Country 10.4.1 Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Escape Therapeutics, Inc. 11.1.1 Escape Therapeutics, Inc. Company Details 11.1.2 Escape Therapeutics, Inc. Business Overview 11.1.3 Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Introduction 11.1.4 Escape Therapeutics, Inc. Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) 11.1.5 Escape Therapeutics, Inc. Recent Development 11.2 Lonza Group Ltd. 11.2.1 Lonza Group Ltd. Company Details 11.2.2 Lonza Group Ltd. Business Overview 11.2.3 Lonza Group Ltd. Allogeneic Stem Cell Therapy Introduction 11.2.4 Lonza Group Ltd. Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) 11.2.5 Lonza Group Ltd. Recent Development 11.3 Osiris Therapeutics (Smith & Nephew) 11.3.1 Osiris Therapeutics (Smith & Nephew) Company Details 11.3.2 Osiris Therapeutics (Smith & Nephew) Business Overview 11.3.3 Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapy Introduction 11.3.4 Osiris Therapeutics (Smith & Nephew) Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) 11.3.5 Osiris Therapeutics (Smith & Nephew) Recent Development 11.4 NuVasive 11.4.1 NuVasive Company Details 11.4.2 NuVasive Business Overview 11.4.3 NuVasive Allogeneic Stem Cell Therapy Introduction 11.4.4 NuVasive Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) 11.4.5 NuVasive Recent Development 11.5 Chiesi Pharmaceuticals 11.5.1 Chiesi Pharmaceuticals Company Details 11.5.2 Chiesi Pharmaceuticals Business Overview 11.5.3 Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Introduction 11.5.4 Chiesi Pharmaceuticals Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) 11.5.5 Chiesi Pharmaceuticals Recent Development 11.6 JCR Pharmaceutical 11.6.1 JCR Pharmaceutical Company Details 11.6.2 JCR Pharmaceutical Business Overview 11.6.3 JCR Pharmaceutical Allogeneic Stem Cell Therapy Introduction 11.6.4 JCR Pharmaceutical Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) 11.6.5 JCR Pharmaceutical Recent Development 11.7 Pharmicell 11.7.1 Pharmicell Company Details 11.7.2 Pharmicell Business Overview 11.7.3 Pharmicell Allogeneic Stem Cell Therapy Introduction 11.7.4 Pharmicell Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) 11.7.5 Pharmicell Recent Development 11.8 Anterogen 11.8.1 Anterogen Company Details 11.8.2 Anterogen Business Overview 11.8.3 Anterogen Allogeneic Stem Cell Therapy Introduction 11.8.4 Anterogen Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) 11.8.5 Anterogen Recent Development 11.9 MolMed S.p.A. 11.9.1 MolMed S.p.A. Company Details 11.9.2 MolMed S.p.A. Business Overview 11.9.3 MolMed S.p.A. Allogeneic Stem Cell Therapy Introduction 11.9.4 MolMed S.p.A. Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) 11.9.5 MolMed S.p.A. Recent Development 11.10 Takeda (TiGenix) 11.10.1 Takeda (TiGenix) Company Details 11.10.2 Takeda (TiGenix) Business Overview 11.10.3 Takeda (TiGenix) Allogeneic Stem Cell Therapy Introduction 11.10.4 Takeda (TiGenix) Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) 11.10.5 Takeda (TiGenix) Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Allogeneic Stem Cell Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Adult Stem Cell Therapy Table 3. Key Players of Human Embryonic Stem Cell Therapy Table 4. Key Players of Induced Pluripotent Stem Cell Therapy Table 5. Key Players of Others Table 6. Global Allogeneic Stem Cell Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Allogeneic Stem Cell Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Allogeneic Stem Cell Therapy Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Allogeneic Stem Cell Therapy Market Share by Regions (2016-2021) Table 10. Global Allogeneic Stem Cell Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Allogeneic Stem Cell Therapy Market Share by Regions (2022-2027) Table 12. Allogeneic Stem Cell Therapy Market Trends Table 13. Allogeneic Stem Cell Therapy Market Drivers Table 14. Allogeneic Stem Cell Therapy Market Challenges Table 15. Allogeneic Stem Cell Therapy Market Restraints Table 16. Global Allogeneic Stem Cell Therapy Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Allogeneic Stem Cell Therapy Market Share by Players (2016-2021) Table 18. Global Top Allogeneic Stem Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Allogeneic Stem Cell Therapy as of 2020) Table 19. Ranking of Global Top Allogeneic Stem Cell Therapy Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Allogeneic Stem Cell Therapy Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Allogeneic Stem Cell Therapy Product Solution and Service Table 23. Date of Enter into Allogeneic Stem Cell Therapy Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Allogeneic Stem Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 26. Global Allogeneic Stem Cell Therapy Revenue Market Share by Type (2016-2021) Table 27. Global Allogeneic Stem Cell Therapy Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Allogeneic Stem Cell Therapy Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Allogeneic Stem Cell Therapy Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Allogeneic Stem Cell Therapy Revenue Market Share by Application (2016-2021) Table 31. Global Allogeneic Stem Cell Therapy Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Allogeneic Stem Cell Therapy Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Allogeneic Stem Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 34. North America Allogeneic Stem Cell Therapy Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Allogeneic Stem Cell Therapy Market Size by Application (2016-2021) (US$ Million) Table 36. North America Allogeneic Stem Cell Therapy Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Allogeneic Stem Cell Therapy Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Allogeneic Stem Cell Therapy Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Allogeneic Stem Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Allogeneic Stem Cell Therapy Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Allogeneic Stem Cell Therapy Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Allogeneic Stem Cell Therapy Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Allogeneic Stem Cell Therapy Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Allogeneic Stem Cell Therapy Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Allogeneic Stem Cell Therapy Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Allogeneic Stem Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Allogeneic Stem Cell Therapy Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Allogeneic Stem Cell Therapy Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Allogeneic Stem Cell Therapy Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Allogeneic Stem Cell Therapy Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Allogeneic Stem Cell Therapy Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Allogeneic Stem Cell Therapy Market Size by Country (2022-2027) & (US$ Million) Table 63. Escape Therapeutics, Inc. Company Details Table 64. Escape Therapeutics, Inc. Business Overview Table 65. Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Product Table 66. Escape Therapeutics, Inc. Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) & (US$ Million) Table 67. Escape Therapeutics, Inc. Recent Development Table 68. Lonza Group Ltd. Company Details Table 69. Lonza Group Ltd. Business Overview Table 70. Lonza Group Ltd. Allogeneic Stem Cell Therapy Product Table 71. Lonza Group Ltd. Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) & (US$ Million) Table 72. Lonza Group Ltd. Recent Development Table 73. Osiris Therapeutics (Smith & Nephew) Company Details Table 74. Osiris Therapeutics (Smith & Nephew) Business Overview Table 75. Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapy Product Table 76. Osiris Therapeutics (Smith & Nephew) Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) & (US$ Million) Table 77. Osiris Therapeutics (Smith & Nephew) Recent Development Table 78. NuVasive Company Details Table 79. NuVasive Business Overview Table 80. NuVasive Allogeneic Stem Cell Therapy Product Table 81. NuVasive Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) & (US$ Million) Table 82. NuVasive Recent Development Table 83. Chiesi Pharmaceuticals Company Details Table 84. Chiesi Pharmaceuticals Business Overview Table 85. Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Product Table 86. Chiesi Pharmaceuticals Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) & (US$ Million) Table 87. Chiesi Pharmaceuticals Recent Development Table 88. JCR Pharmaceutical Company Details Table 89. JCR Pharmaceutical Business Overview Table 90. JCR Pharmaceutical Allogeneic Stem Cell Therapy Product Table 91. JCR Pharmaceutical Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) & (US$ Million) Table 92. JCR Pharmaceutical Recent Development Table 93. Pharmicell Company Details Table 94. Pharmicell Business Overview Table 95. Pharmicell Allogeneic Stem Cell Therapy Product Table 96. Pharmicell Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) & (US$ Million) Table 97. Pharmicell Recent Development Table 98. Anterogen Company Details Table 99. Anterogen Business Overview Table 100. Anterogen Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) & (US$ Million) Table 101. Anterogen Recent Development Table 102. MolMed S.p.A. Company Details Table 103. MolMed S.p.A. Business Overview Table 104. MolMed S.p.A. Allogeneic Stem Cell Therapy Product Table 105. MolMed S.p.A. Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) & (US$ Million) Table 106. MolMed S.p.A. Recent Development Table 107. Takeda (TiGenix) Company Details Table 108. Takeda (TiGenix) Business Overview Table 109. Takeda (TiGenix) Allogeneic Stem Cell Therapy Product Table 110. Takeda (TiGenix) Revenue in Allogeneic Stem Cell Therapy Business (2016-2021) & (US$ Million) Table 111. Takeda (TiGenix) Recent Development Table 112. Research Programs/Design for This Report Table 113. Key Data Information from Secondary Sources Table 114. Key Data Information from Primary Sources List of Figures Figure 1. Global Allogeneic Stem Cell Therapy Market Share by Type: 2020 VS 2027 Figure 2. Adult Stem Cell Therapy Features Figure 3. Human Embryonic Stem Cell Therapy Features Figure 4. Induced Pluripotent Stem Cell Therapy Features Figure 5. Others Features Figure 6. Global Allogeneic Stem Cell Therapy Market Share by Application: 2020 VS 2027 Figure 7. Musculoskeletal Disorder Case Studies Figure 8. Wounds & Injuries Case Studies Figure 9. Cardiovascular Diseases Case Studies Figure 10. Others Case Studies Figure 11. Allogeneic Stem Cell Therapy Report Years Considered Figure 12. Global Allogeneic Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global Allogeneic Stem Cell Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Allogeneic Stem Cell Therapy Market Share by Regions: 2020 VS 2027 Figure 15. Global Allogeneic Stem Cell Therapy Market Share by Regions (2022-2027) Figure 16. Global Allogeneic Stem Cell Therapy Market Share by Players in 2020 Figure 17. Global Top Allogeneic Stem Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Allogeneic Stem Cell Therapy as of 2020 Figure 18. The Top 10 and 5 Players Market Share by Allogeneic Stem Cell Therapy Revenue in 2020 Figure 19. Global Allogeneic Stem Cell Therapy Revenue Market Share by Type (2016-2021) Figure 20. Global Allogeneic Stem Cell Therapy Revenue Market Share by Type (2022-2027) Figure 21. North America Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America Allogeneic Stem Cell Therapy Market Share by Type (2016-2027) Figure 23. North America Allogeneic Stem Cell Therapy Market Share by Application (2016-2027) Figure 24. North America Allogeneic Stem Cell Therapy Market Share by Country (2016-2027) Figure 25. United States Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Allogeneic Stem Cell Therapy Market Share by Type (2016-2027) Figure 29. Europe Allogeneic Stem Cell Therapy Market Share by Application (2016-2027) Figure 30. Europe Allogeneic Stem Cell Therapy Market Share by Country (2016-2027) Figure 31. Germany Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Allogeneic Stem Cell Therapy Market Share by Type (2016-2027) Figure 39. Asia-Pacific Allogeneic Stem Cell Therapy Market Share by Application (2016-2027) Figure 40. Asia-Pacific Allogeneic Stem Cell Therapy Market Share by Region (2016-2027) Figure 41. China Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Allogeneic Stem Cell Therapy Market Share by Type (2016-2027) Figure 49. Latin America Allogeneic Stem Cell Therapy Market Share by Application (2016-2027) Figure 50. Latin America Allogeneic Stem Cell Therapy Market Share by Country (2016-2027) Figure 51. Mexico Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Allogeneic Stem Cell Therapy Market Share by Type (2016-2027) Figure 55. Middle East & Africa Allogeneic Stem Cell Therapy Market Share by Application (2016-2027) Figure 56. Middle East & Africa Allogeneic Stem Cell Therapy Market Share by Country (2016-2027) Figure 57. Turkey Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE Allogeneic Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Escape Therapeutics, Inc. Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2016-2021) Figure 61. Lonza Group Ltd. Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2016-2021) Figure 62. Osiris Therapeutics (Smith & Nephew) Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2016-2021) Figure 63. NuVasive Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2016-2021) Figure 64. Chiesi Pharmaceuticals Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2016-2021) Figure 65. JCR Pharmaceutical Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2016-2021) Figure 66. Pharmicell Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2016-2021) Figure 67. Anterogen Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2016-2021) Figure 68. MolMed S.p.A. Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2016-2021) Figure 69. Takeda (TiGenix) Revenue Growth Rate in Allogeneic Stem Cell Therapy Business (2016-2021) Figure 70. Bottom-up and Top-down Approaches for This Report Figure 71. Data Triangulation Figure 72. Key Executives Interviewed

Escape Therapeutics, Inc. Lonza Group Ltd. Osiris Therapeutics (Smith & Nephew) NuVasive Chiesi Pharmaceuticals JCR Pharmaceutical Pharmicell Anterogen MolMed S.p.A. Takeda (TiGenix)